Women's Health · Full case

Premenstrual Disorder (PMDD)

RCOG GTG 48Symptom diarySuicide-risk screen
PM
Premenstrual Disorder (PMS / PMDD) · Clinical Reasoning Framework v2
GP & SCA · RCOG GTG 48 · Luteal pattern · 2-cycle diary · SSRI & COCP · GnRH · Risk · The mood-disorder mimic
It's the timing that defines itPremenstrual disorders are defined by the cyclical, luteal-phase pattern: symptoms appear in the 1–2 weeks before menstruation and resolve within a few days of bleeding starting, usually with a symptom-free or substantially symptom-free interval. The character of symptoms matters less than the timing
PMS vs PMDDPremenstrual syndrome (PMS) = distressing physical/psychological symptoms in the luteal phase. PMDD (premenstrual dysphoric disorder) is the severe form with prominent mood symptoms (marked irritability, depression, anxiety, lability) causing significant impairment — a recognised psychiatric diagnosis
Diary = the diagnosisA prospective symptom diary over at least 2 menstrual cycles (e.g. the DRSP) substantially strengthens the diagnosis — confirming the luteal-phase pattern with a symptom-free or substantially symptom-free interval — without replacing clinical assessment. Retrospective recall is unreliable and over-diagnoses
Rule out the mimicThe key differential is an underlying mood disorder (depression, anxiety, bipolar) with PREMENSTRUAL EXACERBATION — here symptoms are present all month and worsen premenstrually. The diary distinguishes a symptom-free week (PMDD) from year-round symptoms (mood disorder)
Ask about suicidePMDD carries a significantly increased risk of suicidal thoughts and self-harm, concentrated in the luteal phase. A risk assessment is mandatory — these symptoms can be severe and dangerous even though they remit each month
SSRI works fast hereSSRIs are highly effective for PMDD and can be taken continuously OR only in the luteal phase (they work within days for premenstrual symptoms, unlike in depression). First-line pharmacological options alongside a combined pill
Ovulation suppressionSuppressing ovulation helps: a combined oral contraceptive (continuous/extended, drospirenone-containing often preferred) is a first-line hormonal option; severe refractory cases may need GnRH analogues (with add-back HRT) under specialist care
Stepped & specialistStepwise, chosen by symptoms and preference (lifestyle need not come first; start promptly if severe): CBT, SSRI and/or COCP → optimise or combine → GnRH analogues → (rarely) surgery. Severe, refractory or diagnostically uncertain cases warrant gynaecology / a specialist premenstrual-disorder service
📋 Clinical Stem — Premenstrual Disorder (PMDD)
A 34-year-old woman who feels "like a different person — almost unhinged" for a week or two before every period, with rage, despair and fleeting thoughts she'd be better off gone, then is "completely fine again"
Leila Hassan, 34, describes a pattern she's lived with for years but never named: for about 10–14 days before each period she becomes intensely irritable, tearful and anxious, snaps at her partner and children, feels hopeless, and has had fleeting thoughts that her family "would be better off without me" — then within a day or two of her period starting it lifts and she feels "completely normal, like myself again." She functions well the rest of the month. She is frightened by the intensity and the dark thoughts, ashamed of how she behaves toward her family, and wonders if she is "going mad" or bipolar. She has no symptoms in the week after her period. She is not on hormonal contraception and is otherwise well.
This stem tests the ability to: recognise the cyclical, luteal-phase pattern with a symptom-free follicular phase as premenstrual dysphoric disorder (PMDD) rather than a primary mood disorder; distinguish it from an underlying depression/anxiety/bipolar disorder with premenstrual exacerbation (symptoms all month, worse premenstrually) — using a prospective 2-cycle symptom diary to confirm; perform a mandatory risk assessment for the luteal-phase suicidal thoughts and validate the experience without pathologising her as a "bad mother"; explain the diagnosis and the stepped management (lifestyle/CBT, SSRI continuous or luteal, combined pill/ovulation suppression, GnRH analogues for refractory cases under specialist care); and know when to involve gynaecology/specialist services. The SCA challenge is taking the dark thoughts seriously and confirming the diagnosis with a diary, while relieving her shame and fear of being "mad".
Scenario A — PMDD (this stem) Severe luteal mood symptoms with a symptom-free week and impairment ± luteal suicidal thoughts. Confirm with a 2-cycle diary; risk assess; SSRI (continuous/luteal) ± COCP; lifestyle/CBT; review.
Scenario B — Mood disorder with premenstrual exacerbation (the mimic) Depression/anxiety present all month, worse premenstrually; no symptom-free week on the diary. Treat the underlying disorder; SSRI continuously; mental-health input.
Scenario C — PMS (non-severe) Luteal physical/psychological symptoms that are distressing but not severely impairing. Lifestyle, simple measures, consider COCP/SSRI if needed.
Scenario D — Bipolar disorder History of elevated/manic episodes; premenstrual worsening can occur. Caution with antidepressants; mental-health/specialist input; do not miss bipolarity.
Scenario E — Severe / refractory PMDD Failed first-line treatments, profound impairment, high risk. Specialist premenstrual-disorder service; GnRH analogues with add-back HRT; rarely surgical options.
Key variables to adapt for The luteal pattern + symptom-free week (PMDD) vs all-month symptoms (mood disorder); severity/impairment (PMS vs PMDD); suicide/self-harm risk in the luteal phase; the prospective diary; bipolar history (antidepressant caution); contraceptive needs/desires; previous treatments; perimenopause overlap; the shame and relationship impact.
Steps:
1
Step 1
History — The Cyclical Pattern · The Mimic · Risk · Impact · ICE
▲collapse
The history is built around one defining feature — timing. Premenstrual disorders are confirmed by symptoms in the luteal phase that resolve with menstruation and a symptom-free week afterwards; the crucial distinction is from an underlying mood disorder that is present all month and merely worsens premenstrually. Two things must happen alongside: a risk assessment for the luteal suicidal thoughts, and the relief of Leila's shame and fear that she is "going mad".
🎓 SCA framing — name it, validate it, assess the risk
"What you're describing — feeling like a completely different person for a week or two before your period, then yourself again — is a recognised condition with a name and effective treatments. You're not going mad, and you're not a bad mother. Can I ask some questions to be sure we've got the pattern right, including some about how dark those thoughts get?"
Leila is ashamed and frightened. Naming PMDD as real and treatable, validating her, and then gently assessing the risk are the moves that make this consultation both safe and therapeutic.
1A — Pattern, mimic, risk and impact
QuestionWhy it mattersChanges what?
🟢 OPEN QUESTION"Tell me about the pattern — when in the month it happens, and what you're like in between." The open question lets the cyclical pattern emerge. The hallmark of a premenstrual disorder is luteal-phase symptoms (the 1–2 weeks before the period) that resolve within a few days of bleeding, with a genuinely symptom-free week. Leila's "completely normal in between" is the key feature that points to PMDD rather than a mood disorder.In SCA: asking what she's like between episodes is the single most diagnostic question — it tests for the symptom-free follicular phase. Luteal symptoms + symptom-free week → PMDD
🚩 The mimic — mood disorder with premenstrual exacerbation"Are there low days or anxious days at other times of the month too, even if they're worse before your period?"The pivotal differential. If symptoms are present throughout the month and merely worsen premenstrually, this is an underlying depression/anxiety (or bipolar) disorder with premenstrual exacerbation — managed as the primary disorder, not as PMDD. A true symptom-free follicular phase is what defines a premenstrual disorder. The prospective diary settles it.All-month symptoms → primary mood disorder (treat as such). Symptom-free week → PMDD.Defines PMDD vs mood disorder2-cycle symptom diary
🚩 Risk assessment"You mentioned thoughts that your family would be better off without you — can you tell me more? How dark do those thoughts get, and have you ever thought about acting on them?"Mandatory. PMDD significantly raises suicidal ideation and self-harm risk, concentrated in the luteal phase. Explore the nature, intensity, plans, intent and protective factors of Leila's thoughts, and how she is during the worst days. The cyclical, remitting nature does NOT make the risk trivial.Active intent/plan → urgent mental-health assessment + safety plan; luteal-phase safety planning.Active risk → urgent assessment
Bipolar & psychiatric history"Have you ever had periods of feeling unusually high, sped up, or not needing sleep? Any past depression or mental-health treatment?"A history of elevated/manic episodes raises bipolar disorder — important because antidepressants need caution and the management differs. Past depression/anxiety also shapes the differential and treatment.Bipolar features → caution with SSRIs; mental-health/specialist input.Bipolar → antidepressant caution
Impact & relationships"How is this affecting your relationship, your children, your work?"Severity is defined by impairment. The impact on Leila's family — and her shame about it — is central both to the PMDD (vs PMS) classification and to the therapeutic relationship. Naming that the behaviour is driven by a treatable condition relieves guilt and supports engagement.Significant impairment → PMDD; treat actively; address relationship impact/guilt.Impairment defines severity; address guilt
Reproductive & treatment history"Where are you with contraception and family plans? What have you already tried for this?"Contraceptive needs and plans shape hormonal options (a combined pill can both treat PMDD and provide contraception); previous treatments and their effect guide the next step. Perimenopause can overlap and alter the picture.Contraceptive need → COCP option; previous treatments → tailor next step.Align treatment with contraception/plans
1B — Red flags
🚨

Red Flags — the cyclical illness that can still be dangerous

Red flagWhy dangerousAction
Active suicidal ideation / self-harm (often luteal-phase)PMDD substantially increases suicide risk; intense luteal-phase despair can lead to acts even though it remits.Risk assessment; urgent mental-health/crisis input if intent/plan; luteal safety plan
Underlying mood disorder with premenstrual exacerbationMisdiagnosing a year-round depression/anxiety as PMDD leads to under-treatment of the primary illness.Prospective diary; treat the primary disorder; mental-health input
Bipolar disorderAntidepressants can destabilise mood; bipolarity is easily missed.Screen for mania/hypomania; caution with SSRIs; specialist/mental-health input
Severe functional collapse / safeguarding concernSevere PMDD can endanger the woman and affect care of children.Urgent support; consider safeguarding; specialist referral
Postpartum / perimenopausal overlapOther hormonal mood disorders can coexist or confuse the picture.Clarify with history/diary; treat appropriately
Refractory severe symptomsHigh morbidity; needs escalation beyond primary care.Specialist premenstrual-disorder service / gynaecology
1C — ICE
💭 Ideas
"What do you think is happening to you — you mentioned wondering if you're bipolar or 'going mad'?"
Leila fears she is mentally ill in a frightening, permanent way. Surfacing this lets you name PMDD as a recognised, hormone-linked, treatable condition — and to explain how it differs from bipolar disorder — which is profoundly reassuring and reframes her self-blame.
😟 Concerns
"What worries you most — the dark thoughts, or how you are with your family?"
Her concerns are the suicidal thoughts and the shame about her behaviour toward her children. Naming both lets you assess the risk properly and relieve the guilt by attributing the behaviour to a treatable condition rather than to her character.
🎯 Expectations
"What were you hoping for from coming today?"
She may want an instant fix or fear being dismissed as "hormonal". Naming this lets you set out the plan — confirm with a diary, assess safety, and start effective treatment (often quickly with an SSRI) — so she leaves with hope and a concrete path.
1D — Psychosocial context
🤝 Shame, dismissal, and a real illness hidden as "just hormones"

Premenstrual disorders sit at a painful intersection of stigma: women are told it's "just PMS" and dismissed, while privately they experience symptoms severe enough to threaten relationships and, at the extreme, life. Many carry deep shame about how they behave during the luteal phase and blame themselves. The transformative clinical act is to take it seriously — to name PMDD as a genuine, hormone-linked condition with effective treatments, to separate the woman's worth from her premenstrual symptoms, and to assess the very real luteal-phase risk that the cyclical remission can hide.

🙎 "Am I a bad mother?"

Attribute the behaviour to a treatable condition; separate it from her character.

"The way you are with your family in those two weeks isn't who you are — it's a symptom of a hormone-driven condition. That you feel so awful about it tells me how much you love them. We can treat this."
🧠 "Am I going mad / bipolar?"

Reassure and differentiate clearly from bipolar disorder.

"You're not going mad. Because it comes and goes with your cycle and you're completely well in between, this is premenstrual dysphoric disorder rather than bipolar — and that distinction matters, because it's very treatable."
🆘 Taking the dark thoughts seriously

The remitting nature doesn't reduce the risk; assess and safety-plan.

"I'm really glad you told me about those thoughts — they're part of how severe this can get, and I take them seriously even though they lift after your period. Let's make a plan for the worst days and get you treatment so they ease."
🚫 Undoing dismissal

Counter the "just PMS" message she may have internalised.

"This isn't something to just put up with or be embarrassed about. It's a recognised condition, and there are treatments that genuinely work — you deserve to feel like yourself all month."
1E — PMH · FH · Drug history · Social history: management impact
🧬 PMH / FH: changes management
FactorWhy it mattersManagement impact
Past depression, anxiety or postnatal depressionWomen with PMDD often have a personal history of mood disorder. A past episode does not rule out PMDD, but it raises the chance that the diary will show symptoms all month, not just a premenstrual worsening.Take the diary seriously before labelling. If symptoms run all month, manage as depression or anxiety (NICE NG222 for depression). A previous good response to one SSRI makes that SSRI a sensible first choice.
Episodes of elevated mood; FH of bipolar disorderAn SSRI alone can tip someone with undiagnosed bipolar disorder into mania or a mixed state. Irritability and mood swings are features of both conditions.Assess the nature, duration and impact of any highs (a family history alone is not enough). If bipolar disorder is suspected, seek mental-health advice before an SSRI alone (NICE NG222, CG185).
Migraine, especially with auraMigraine with aura makes combined hormonal contraception UKMEC 4 (unacceptable risk) because of stroke risk. Menstrual migraine is common in the same group of women.No combined pill. Choose an SSRI and CBT. If ovulation suppression is needed later, transdermal oestradiol is a specialist decision.
Personal or FH of VTE, thrombophiliaA personal history of VTE is UKMEC 4 for combined hormonal contraception. Drospirenone COCs carry a higher VTE risk than levonorgestrel COCs.Avoid the COC. Check the family history in a first-degree relative against UKMEC 2025 before prescribing.
Renal impairment, hyperkalaemia riskDrospirenone is anti-mineralocorticoid and can raise potassium.Avoid drospirenone in renal impairment. Consider checking potassium in the first cycle if she takes potassium-raising drugs (SPC / SPC).
Endometriosis, heavy or painful periodsPelvic pain presented as "PMS" is on a different pathway. Both conditions can co-exist, and continuous hormonal treatment may help both.Assess on its own terms (NICE NG73 endometriosis; NG88 heavy menstrual bleeding).
💊 Drug & social history: changes management
FactorWhy it mattersManagement impact
Current or recent hormonal contraceptionSome women develop mood symptoms on progestogen-only methods or on a combined pill containing an older progestogen. The hormone-free interval can itself bring symptoms back.Map the timing of symptoms against each method. Changing method or regimen may be the treatment.
Supplements: vitamin B6, herbal productsHigh-dose B6 causes peripheral neuropathy. St John's wort interacts with SSRIs (serotonin toxicity) and makes the combined pill less effective.Ask about every product and its dose. NHS advice: no more than 10 mg/day of B6 from supplements unless a doctor advises more. Stop St John's wort before starting an SSRI or COC.
NSAIDs for period pain, triptans, tramadolSSRIs with NSAIDs raise bleeding risk. SSRIs with triptans or tramadol raise the risk of serotonin syndrome.Check the interaction in the SPC. Consider gastroprotection if she uses NSAIDs regularly alongside an SSRI.
Smoking; ageAged 35 or over and smoking 15 or more cigarettes a day makes combined hormonal contraception UKMEC 4.Leila is 34 and does not smoke. Ask again at every contraceptive review.
Alcohol and drugsAlcohol use often rises in the luteal phase to cope. It worsens mood and disinhibition and makes impulsive self-harm more likely.AUDIT-C. Name alcohol as a luteal risk amplifier in the safety plan.
Children, relationship, workImpairment is what defines PMDD. Luteal conflict at home also raises the question of domestic abuse, which can present as "irritability".Ask about safety at home, alone and safely. Think about the welfare of the children. Plan work around the luteal phase where possible.
Pregnancy plansA combined pill and ovulation suppression are incompatible with trying to conceive.If she is trying for a baby, use luteal-phase or continuous SSRI plus CBT, and discuss the SSRI in pregnancy before conception.
🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills
Key phrases that score
"What are you like in the week AFTER your period?" — tests for the symptom-free phase that defines PMDD.
"Tell me more about the thoughts that your family would be better off without you — have you thought about acting on them?" — mandatory risk assessment.
"This is a recognised, treatable condition — you're not going mad or a bad mother." — validates and reframes.
Deductions
  • Not assessing suicide/self-harm risk
  • Not distinguishing PMDD from a year-round mood disorder (no diary)
  • Dismissing it as "just PMS"; not screening bipolar
  • Leaving her shame and fear unaddressed
🔴 Red
No risk assessment; PMDD vs mood disorder not distinguished; "just PMS" dismissal; bipolar not screened; shame unaddressed
🟠 Amber
Cyclical pattern recognised; some risk assessment; diary not arranged; validation partial; ICE partial
🟢 Green
Luteal pattern + symptom-free week established; mimic excluded via diary; full risk assessment; bipolar screened; validated & de-shamed; ICE all three
2
Step 2
Triage — Acute Risk · Specialist · Routine Primary Care
▲collapse
The triage hinge is risk: active suicidality needs urgent mental-health input; severe/refractory or diagnostically uncertain disease needs specialist services; and most PMS/PMDD is diagnosed (via diary) and treated in primary care.
🔴 Urgent

Same day

Risk
  • Active suicidal intent / planUrgent mental-health/crisis assessment; safety plan
  • Severe functional collapse / safeguardingUrgent support; safeguarding if children at risk
  • Suspected bipolar disorderMental-health advice (not a same-day crisis unless risk); SSRI caution
🟠 Specialist

Refer

Gynae / PMD service
  • Severe / refractory PMDDSpecialist premenstrual-disorder service; GnRH analogues
  • Diagnostic uncertaintyAfter diary; specialist review
  • Considering ovulation suppression escalationGynaecology
🟢 Routine

Primary care

Diagnose & treat
  • Suspected PMS/PMDD2-cycle diary; lifestyle/CBT; SSRI ± COCP
  • Mood disorder w/ premenstrual exacerbationTreat primary disorder
  • Established PMDD on treatmentReview, optimise, monitor risk
🎓 SCA Checkpoint — Step 2Tasks
Triage rationale
"We can confirm and treat this here. The one thing I want to be sure about today is your safety on the worst days — and if the dark thoughts ever feel like more than passing thoughts, here's exactly who to contact."
Deductions
  • Not escalating active suicidality
  • Not recognising when specialist/GnRH escalation is needed
3
Step 3
Assessment — Mental State · Risk Formulation · Exclude Other Causes
▲collapse
"Examination" is a mental state assessment and a risk formulation, plus consideration of physical contributors. There is no physical sign of PMDD — the assessment confirms the mood picture, quantifies risk, and excludes mimics.
🧠 Mental state & risk
DomainWhat to assess
Mood / affectCurrent state (may be follicular and well); reactivity; lability.
Cyclical history corroborationPattern, symptom-free week, impairment.
RiskSuicidal ideation/plan/intent, self-harm, protective factors — including how she is on the worst luteal days.
Bipolar screenPast mania/hypomania; family history.
⚕️ Physical / other
CheckWhy
Thyroid / anaemia considerationCan contribute to mood/fatigue if clinically indicated.
Perimenopausal featuresOverlap of hormonal mood symptoms in older women.
BP / suitability for COCPIf a combined pill is being considered.
Pregnancy statusRelevant to treatment choice.
🎓 SCA Checkpoint — Step 3TasksGlobal Skills
Demonstrating the formulation
"From what you've told me, the picture is severe mood symptoms confined to the two weeks before your period, with a clear well week afterwards, and some dark thoughts at the worst point — that's a premenstrual disorder, and I want to confirm it with a diary and keep you safe in the meantime."
Deductions
  • No explicit risk formulation
  • Not screening bipolar / excluding mimics
4
Step 4
Investigations — The Prospective Diary · Selective Bloods
▲collapse
The single most important "investigation" is a prospective symptom diary over at least two cycles — it confirms the luteal pattern with a symptom-free follicular phase and separates PMDD from a year-round mood disorder. Bloods are selective.
📓 Symptom diary
ElementDetail
Prospective ≥2 cyclesDaily rating (e.g. DRSP — Daily Record of Severity of Problems); confirms timing and severity.
Looks forLuteal symptoms resolving with menses + a symptom-free week → PMDD/PMS. Symptoms all month → mood disorder.
Why prospectiveRetrospective recall over-diagnoses; the diary substantially strengthens the diagnosis but does not replace clinical assessment.
Safety alongsideDon't delay risk management while the diary is collected; safety-plan now.
🧪 Bloods (selective)
TestWhen
TFTsIf thyroid disease suspected (mood/fatigue).
FBC / ferritinIf anaemia contributing to fatigue.
FSH (older women)Only if perimenopause is genuinely in question — not for routine PMDD. Consider only at age 40–45 with cycle change; at 45+ diagnose perimenopause clinically, and FSH is unreliable on combined hormonal contraception (NICE NG23).
No hormone "test" for PMDDThere is no blood test that diagnoses PMDD — it is clinical + diary.
🎓 SCA Checkpoint — Step 4Tasks
Key reasoning
"I'd like you to keep a daily symptom diary over the next two cycles — it confirms the pattern and rules out a year-round low mood. We won't wait for it to keep you safe, though, and if you're severe we can start treatment now."
Deductions
  • Diagnosing PMDD on retrospective recall alone
  • Ordering hormone profiles to "diagnose" PMDD
5
Step 5
Diagnosis — PMS · PMDD · Mood Disorder w/ Exacerbation · Bipolar
▲collapse
Name the disorder by the diary-confirmed pattern and severity — and explicitly separate PMDD from the year-round mood disorder it mimics, because the treatments and risks differ.
DiagnosisDiscriminating features
PMDDSevere luteal mood symptoms (marked irritability, depression, anxiety, lability) with significant impairment and a symptom-free week (Leila).
PMSDistressing luteal physical/psychological symptoms, less severe impairment.
Mood disorder + premenstrual exacerbationDepression/anxiety present all month, worse premenstrually; no symptom-free week on the diary.
Bipolar disorderHistory of mania/hypomania; premenstrual worsening can occur; antidepressant caution.
Perimenopausal mood symptomsHormonal mood change around the menopause transition.

🚩 The symptom-free week is the whole game

The defining discrimination is whether there is a genuine symptom-free follicular phase. If yes (Leila), the diagnosis is a premenstrual disorder — PMDD given the severity, mood predominance, impairment and luteal suicidal thoughts. If symptoms persist throughout the month, it is a primary mood disorder with premenstrual exacerbation, treated as such. The prospective diary makes the call. For Leila: likely PMDD, with a mandatory ongoing risk plan and bipolar screened out.

🎓 SCA Checkpoint — Step 5Tasks
Explaining it plainly
"This looks like premenstrual dysphoric disorder — a severe, hormone-linked mood condition tied to the two weeks before your period. We'll confirm it with the diary, but because you're so clearly well in between, this isn't a constant depression or bipolar — and it's very treatable."
Deductions
  • Labelling PMDD without the symptom-free-week criterion
  • Missing an underlying mood/bipolar disorder
6
Step 6
Referral — Mental Health · Gynaecology · Specialist PMD Service
▲collapse
Most PMS/PMDD is managed in primary care. Referral is for acute risk (mental health), refractory or severe disease and ovulation-suppression escalation (gynaecology / specialist premenstrual-disorder service), and diagnostic uncertainty.
ReferralWho / whenUrgency
🔴 Mental health / crisisCurrent suicidal intent or plan, recent serious self-harm, inability to remain safe, psychosis or risk to a child.Urgent / same day
GynaecologyConsidering ovulation suppression escalation (GnRH analogues with add-back HRT); refractory hormonal management.Routine
Specialist premenstrual-disorder serviceSevere / refractory PMDD; diagnostic uncertainty after diary; complex cases.Routine
Psychology / CBTCBT is effective for PMDD — first-line psychological option.Routine
Mental-health teamSuspected bipolar disorder; persistent all-month mood disorder; risk still significant despite a safety plan; diagnostic uncertainty.As needed
🎓 SCA Checkpoint — Step 6Tasks
Knowing the thresholds
"We'll start treatment here. If it doesn't settle things, there's a specialist service and stronger hormonal options through gynaecology — and if your safety were ever a concern, I'd involve the mental-health team straight away."
Deductions
  • Not escalating active risk to mental health
  • Not knowing the specialist/GnRH route for refractory disease
7
Step 7
Management — Expectation · Goals · Lifestyle/CBT · RCOG Ladder · Drug Cards · Psychosocial · Follow-Up · Monitoring · Safety-Net
▲collapse
Management is stepped: lifestyle and CBT, then SSRIs (continuous or luteal-phase only) and/or a combined pill to suppress ovulation, escalating to GnRH analogues under specialist care for refractory disease — with a luteal-phase safety plan running throughout given the suicide risk.
7A — Address the patient's expectation first: validate → explain → negotiate
🤝
Leila hopes for a quick fix and fears she'll be dismissed as "hormonal" or labelled bipolar. Name both, then agree a plan
1
Validate: name what she came for

Leila wants an explanation, to hear that she isn't "going mad", and something that works before her next bad fortnight. She may also expect a blood test for "hormone levels", or fear being told to "just put up with it". Say these expectations out loud before you explain anything. Otherwise asking for a diary can sound like being fobbed off.

"I suspect you came wanting two things: an answer to what's happening, and something that helps before your next bad couple of weeks. I think we can do both today, and I want you to leave with a plan, not just a leaflet."
2
Explain: timing is the diagnosis, and there's no blood test

Hormone levels are normal in PMS and PMDD. The problem is the brain's sensitivity to the normal rise and fall of hormones, so a blood test cannot confirm it. What confirms it is the pattern: symptoms before the period, gone by the end of it, and a week that is genuinely clear. A daily diary kept over 2 cycles shows this and also rules out a depression that runs all month (RCOG GTG 48).

"Your hormone levels are almost certainly normal. What's different is how strongly your brain reacts to the normal monthly changes. That's why a blood test won't show it, but a daily diary will. It also gives us a baseline, so we can see whether treatment is really working."
3
Negotiate: the diary comes first, but safety does not wait

The diary does not have to delay help. Keep her safe and start the things that cannot harm her today: direct questions about the suicidal thoughts, a written luteal-phase safety plan with crisis numbers, lifestyle changes, a CBT or self-help referral, and information. RCOG GTG 48 asks for a 2-cycle diary before a definitive diagnosis, unless urgent treatment is needed. Severe PMDD, marked impairment or significant risk justify starting an SSRI or hormonal treatment promptly while the diary continues; Leila's severity and luteal suicidal thoughts put her in that group. If you do, first screen for bipolar disorder, remember that a year-round depression has not yet been excluded, keep the diary going, review within 1 week (NICE NG222), and record the reason. Seek same-day mental-health advice instead if there is any intent or plan.

"I'd like you to start the diary tonight. Alongside it, we'll make a plan for your worst days, and I'll refer you for CBT, which really does help with this. Usually we'd wait for two months of diary before starting a medicine. Because the dark thoughts are so hard on those days, we can talk about starting one sooner. If we do, I'll see you again within a week."
Key principle: RCOG GTG 48 asks for a prospective diary over 2 cycles before a definitive diagnosis, and that is the standard to explain. The diary exists to get the diagnosis right. It is never a reason to leave risk unmanaged or to send her away with nothing. Where symptoms are severe or risk is significant, treatment can start while the diary continues. Whatever you decide about starting a drug early, the luteal suicidal thoughts are dealt with today, not after the diary: ask directly, agree a written safety plan, give crisis numbers (999 or A&E if in immediate danger; NHS 111 mental-health option; Samaritans: number on their website), and book follow-up.
7B — Why treatment matters: goals tailored to this patient
Treatment goals for Leila
Safe through every luteal phase, with a written plan she and (with consent) her partner knowNo self-harm; the dark thoughts named and reviewed each visit Diagnosis confirmed on a 2-cycle prospective diary (DRSP)A clear drop in diary scores after 2–3 treated cycles Fewer "lost days": work and parenting through the luteal phaseLess conflict at home; the guilt reframed as a symptom, not her character A treatment that also fits her contraception and family plansKnow the next step and when to refer if first line fails
Motivational language: tailored to Leila
"You've been getting through two bad weeks a month for years on willpower alone. What we're adding now is treatment. Most women with this get a real improvement from the first treatments we try, and there are more options after that if they don't work."
"The diary is also for you. When you can see on paper that the bad days line up with your cycle, it's much easier to believe it's the condition and not you. It lets you plan big things for your good weeks, too."
2 cycles
Prospective daily symptom diary (e.g. the DRSP) before a definitive diagnosis — treatment can start sooner if severe or risk is significant. Recall of past cycles over-reports symptoms (RCOG GTG 48, 2016)
40% · 5–8%
About 4 in 10 women report premenstrual symptoms, and 5–8% have severe PMS. PMDD sits at this severe end (RCOG GTG 48)
≥5 of 11
DSM-5 PMDD needs at least 5 symptoms in the final week before menses, including at least 1 core mood symptom (lability, irritability, depressed mood or anxiety), confirmed on prospective ratings over at least 2 cycles
Day 15–28
Luteal-phase SSRI regimen in a 28-day cycle. RCOG GTG 48 recommends luteal or continuous dosing. Dose per SPC and local formulary; off-label for PMS in the UK
9–12 vs 5–7
VTE cases per 10,000 women per year on drospirenone COCs, compared with 5–7 on levonorgestrel or norethisterone COCs and about 2 in non-users who are not pregnant (MHRA Drug Safety Update, Feb 2014)
1 week
Review within 1 week of starting or increasing an antidepressant if aged 18–25 or at increased suicide risk (NICE NG222). Luteal suicidal thoughts put Leila in the "increased risk" group
>6 months
A GnRH analogue used for more than 6 months needs add-back HRT, with annual bone density monitoring on long-term treatment. Specialist only (RCOG GTG 48)
≤10 mg/day
NHS advice on the upper limit of vitamin B6 from supplements unless a doctor advises otherwise. Higher doses risk peripheral neuropathy (RCOG GTG 48 warns about high doses)
7C — Non-medication management: mechanism + evidence + tailored advice
RCOG GTG 48 treats lifestyle measures and CBT as first-line options, not a warm-up before the "real" treatment. They are safe to start on the day she is seen, can run alongside the diary, and still help after medication is stopped. Each card names what it changes and what to aim for.
🧠
Cognitive Behavioural Therapy
Target: NHS Talking Therapies self-referral this week
Mechanism

CBT does not change the hormonal trigger. It changes how the luteal thoughts ("I'm a terrible mother", "they'd be better off without me") are read and acted on. It builds coping plans for the predictable bad days and reduces the shame spiral that follows an outburst.

Practical

Give her the local NHS Talking Therapies self-referral route. Group, guided self-help and individual formats all exist. Tell the service about the premenstrual pattern and the luteal thoughts so they can adapt the work to it. It combines well with an SSRI or COC.

RCOG GTG 48: CBT should be considered routinely as a treatment option for severe PMS
📔
Symptom Diary + Psychoeducation
Target: daily DRSP (or app) for 2 cycles
Mechanism

Seeing the pattern on paper turns an unpredictable "different person" into a predictable, time-limited phase. That helps her plan, eases self-blame, and helps her partner understand. It is also the outcome measure for every later step.

Practical

Paper DRSP or a cycle-tracking app that records symptom severity each day. Rate every day, including the good ones, because the good days prove the symptom-free week. Mark the days bleeding starts. Bring it to each review.

RCOG GTG 48: prospective recording over 2 cycles before treatment
🏃‍♀️
Regular Aerobic Exercise
Target: most days, not just during bad weeks
Mechanism

Aerobic exercise improves mood, sleep and stress reactivity. Its benefit on premenstrual symptoms builds over the whole cycle, not on the bad day itself.

Practical

Choose something that fits around two children: brisk walks on the school run, a home workout, or a regular class booked for the week before her period so it happens anyway. Aim for consistency, not intensity.

RCOG GTG 48 lists exercise among first-line measures; evidence quality is modest but harm is minimal
😴
Sleep, Caffeine, Alcohol
Target: protect sleep in the luteal phase; alcohol-free on the worst days
Mechanism

Luteal insomnia amplifies irritability and hopelessness. Alcohol lifts mood briefly, then worsens it and removes inhibitions. That matters because impulsive self-harm is more likely under the influence.

Practical

Keep regular sleep and wake times. Avoid caffeine after midday in the luteal week. Keep no alcohol at home on the diary's worst days, and put this in the safety plan. Smaller, regular meals can help if cravings and energy dips drive irritability.

Low-risk measures endorsed by RCOG GTG 48 as part of first-line care
🗓️
Luteal-Phase Planning
Target: diary-guided plan for demanding events
Mechanism

Predictable symptoms can be planned around. Cutting avoidable stress in the known window lowers the chance of the conflict that leaves her ashamed.

Practical

Schedule difficult conversations, deadlines and big family events in the follicular phase where she can. Agree a "time-out" signal with her partner for flashpoints. Share the plan with a trusted person.

Clinical teaching: fewer luteal flashpoints means less guilt after them
🌿
Supplements: Honest Framing
Target: informed choice, safe doses
Mechanism

Agnus castus (chasteberry) has some trial support, but safety data are limited. Calcium and vitamin D have some supportive evidence. Vitamin B6 is listed by RCOG, but high doses cause neuropathy.

Practical

If she prefers a non-prescription option, suggest a product with the UK Traditional Herbal Registration (THR) mark. Keep B6 within NHS limits. Avoid St John's wort if an SSRI or COC is likely. Do not let a supplement delay effective treatment for PMDD with luteal suicidal thoughts.

RCOG GTG 48: limited evidence; B6 neuropathy warning at high doses
7D — Prescribing guide: RCOG Green-top 48 treatment ladder
RCOG Green-top Guideline No. 48, Management of Premenstrual Syndrome (2016; published in BJOG 2017), is still the current UK guideline, and its treatment ladder applies in primary care. First line is lifestyle and CBT, a drospirenone-containing COC and/or a low-dose SSRI (continuous or luteal phase). Second line is optimising the SSRI (dose or regimen), combining an SSRI with an eligible COC, or spironolactone for physical symptoms; transdermal oestradiol with progestogen protection is off-label and usually specialist-supported. Third line is a GnRH analogue with add-back HRT, and surgery is the last resort. Both of these are specialist decisions. Progesterone and progestogens alone are not recommended. SSRIs are off-label for PMS in the UK, and all doses are per SPC.
LineOptions (RCOG GTG 48)GP notes for Leila
First line: all womenExercise, sleep and stress reduction; CBT; information and diary. Low-dose vitamin B6 or agnus castus if she prefers, noting limited evidence and the B6 neuropathy warning.Start today, whatever else is chosen.
First line: moderate–severe / PMDDNew-generation COC containing drospirenone. Emerging data favour continuous use over cyclical use. And/or low-dose SSRI (e.g. sertraline, fluoxetine, citalopram, escitalopram), continuous or luteal phase only (day 15–28).Leila has luteal suicidal thoughts and mood-dominant symptoms, is not on contraception, and is open to the pill. Both options suit her. An SSRI treats the mood symptoms most directly. A COC also gives contraception but needs a UKMEC 2025 check and a VTE discussion. Choose by preference, or combine them.
Second lineOptimise the SSRI (dose, or switch between continuous and luteal), or combine an SSRI with an eligible COC. Or transdermal oestradiol (off-label, usually specialist-supported; may not reliably suppress ovulation) (RCOG cites 100 microgram patches twice weekly, or gel) with progestogen endometrial protection: the LNG-IUS 52 mg, or a 10–12-day cyclical course of oral or vaginal progesterone, at the lowest possible progestogen dose.Oestradiol patches are not contraceptive. Use the LNG-IUS or a barrier method. This step is usually started with gynaecology advice.
Third line: specialistGnRH analogue to create a reversible medical menopause. Add-back HRT (continuous combined HRT or tibolone) if used for more than 6 months, with annual DEXA on long-term treatment. Also used for about 3 months as a diagnostic test.Secondary care only. The GP's job is a referral letter with the diaries before and during treatment, the doses and durations tried, contraceptive needs and bone risk factors.
Fourth line: specialistHysterectomy with bilateral salpingo-oophorectomy, only after medical treatment has failed and after a GnRH test of cure that also shows she tolerates HRT. HRT afterwards (oestrogen-only once the uterus is removed), particularly if under 45.Endometrial ablation and hysterectomy that keeps the ovaries are not recommended: ovulation, and the symptoms, continue.
Physical symptomsSpironolactone can be used for physical symptoms such as bloating (off-label; dose per SPC).Minor for Leila, whose symptoms are mostly mood.
Do not useProgesterone or progestogens as PMS treatment: no clinically meaningful benefit, and they can reproduce symptoms. High-dose B6. Danazol only rarely, in specialist hands, because of irreversible virilisation.If she has been given cyclical progesterone in the past, stop it.
Choosing the SSRI regimen: continuous or luteal?
  • Luteal phase only (day 15 to menses): suits regular cycles, purely premenstrual symptoms, and women who want less drug exposure or fewer sexual side effects.
  • Continuous: suits irregular cycles, co-existing anxiety or depression, symptoms starting early in the luteal phase, or poor response to luteal dosing.
  • SSRIs act within days on premenstrual symptoms, unlike in depression, which is why the luteal regimen works. RCOG GTG 48 supports either regimen.
  • Stopping: luteal dosing stops each cycle at menses. After continuous use, taper the dose rather than stopping abruptly.
  • Dose per SPC and local formulary. Citalopram and escitalopram have maximum doses because of QT prolongation (MHRA Drug Safety Update, Dec 2011).
Choosing a COC: drospirenone, and how to take it
  • RCOG GTG 48: drospirenone-containing COCs may be effective and should be considered first-line pharmaceutical options. Emerging data favour continuous rather than cyclical use, because the hormone-free interval can bring symptoms back.
  • Continuous or tailored regimens are outside the product licence but are supported by the CoSRH guideline Combined Hormonal Contraception (2019, amended 2023; now published by CoSRH). Explain this and record it.
  • Before prescribing: UKMEC 2025 check (migraine with aura, VTE history, smoking at 35 or over, BMI, BP), BP, BMI, and a drug interaction check.
  • Discuss VTE honestly: the absolute risk is small, but it is higher than with levonorgestrel COCs (MHRA 2014).
  • If she has had a progestogen-driven mood reaction in the past, review after 3 months. Some women do worse on any hormonal method.
7D (summary) — The stepped plan and safety support at a glance
💊 Treatment ladder
StepDetail
Lifestyle & CBTExercise, sleep, stress reduction; CBT is effective; psychoeducation reduces shame.
SSRIFirst-line pharmacological — continuous OR luteal-phase only (works within days for PMDD); e.g. sertraline, fluoxetine, citalopram. Counsel on use and side effects.
Combined pill (ovulation suppression)Continuous/extended COCP, drospirenone-containing often preferred; also provides contraception. Assess COCP suitability.
Escalation (specialist)Second line: higher-dose SSRI or SSRI + COC (primary care), or transdermal oestradiol with progestogen protection (usually with gynaecology advice). Third and fourth line, specialist only: GnRH analogues with add-back HRT for severe refractory disease; rarely hysterectomy with bilateral salpingo-oophorectomy as a last resort (RCOG GTG 48).
OtherSome use of certain supplements is reported; evidence varies — don't oversell.
🛡️ Safety, support & follow-up
ElementDetail
Luteal safety planExplicit plan for the worst days; crisis contacts; involve partner with consent; remove means if relevant.
Relationship supportHelp her and (with consent) her partner understand the condition; reduce guilt.
Diary & reviewConfirm diagnosis on the diary; review response and risk early; adjust the ladder.
Bipolar cautionIf any bipolar features emerge, reassess before/with antidepressants.
Validate & instil hopeEmphasise that effective treatment exists and most improve.
7E — Drug reference cards: premenstrual disorder treatments
No interactive medication chooser exists for this topic yet. Use the ladder in 7D and the cards below. Doses are per SPC unless stated, because RCOG GTG 48 does not give primary-care SSRI or COC doses for PMS. SSRIs for PMS and continuous COC regimens are both off-label in the UK, so explain this and record it.
SSRIs: continuous or luteal-phase
Sertraline · Fluoxetine · Citalopram · Escitalopram
First line (RCOG)Low dose; dose per SPC
✓ Prefer when
Mood-dominant PMS or PMDD: irritability, low mood, anxiety, lability. Leila's picture.
A COC is contraindicated (e.g. migraine with aura, VTE history) or not wanted.
Trying to conceive: a luteal regimen or continuous SSRI plus CBT, after discussing SSRI use in pregnancy.
✗ Avoid / caution
Possible bipolar disorder: no SSRI alone; get psychiatric advice first (NICE CG185).
MAOI use; QT prolongation (citalopram and escitalopram have maximum doses, MHRA 2011); bleeding risk with NSAIDs or anticoagulants; triptans, tramadol or St John's wort (serotonin syndrome); epilepsy.
Aged under 25: higher risk of suicidal behaviour early in treatment, so monitor closely (MHRA). Aged 18–25 or at increased risk: review within 1 week (NICE NG222).
⚠ Side effects
Nausea, headache, sleep change, restlessness or anxiety at the start, sexual dysfunction, sweating. Usually settle within 1–2 weeks. Luteal dosing means the start-up effects can recur each cycle.
🔬 Monitor
Mood and suicidality at every review. Early review after starting. Repeat the diary after 2–3 treated cycles. Taper, don't stop abruptly, after continuous use.
💬 Counselling

"This works differently for premenstrual symptoms than for depression. It often helps within days, which is why some women take it only in the two weeks before their period. The first week can bring some nausea or jitteriness. If your thoughts get darker, not better, tell us the same day."

SCA: offering the luteal-only option, and knowing it works quickly in PMDD, shows you know this topic rather than generic depression care. Name that it is off-label.

Combined oral contraceptive containing drospirenone
Ethinylestradiol + drospirenone (e.g. 30 microgram/3 mg or 20 microgram/3 mg products)
First line (RCOG)Continuous preferred; product per SPC
✓ Prefer when
She also wants contraception, and no UKMEC 3/4 condition applies.
Physical symptoms (bloating, breast tenderness) alongside mood symptoms. Suppressing ovulation targets the trigger.
She prefers a hormonal option to an antidepressant.
✗ Avoid if
UKMEC 4: e.g. migraine with aura, personal history of VTE, aged 35 or over and smoking 15 or more a day. Check every condition in UKMEC 2025.
Renal impairment or hyperkalaemia risk (drospirenone is anti-mineralocorticoid).
Enzyme-inducing drugs, including St John's wort, reduce effectiveness. Past mood deterioration on hormonal contraception: try, but review early.
⚠ Side effects
VTE: 9–12 per 10,000 women-years, compared with 5–7 for levonorgestrel COCs (MHRA 2014). Also breakthrough bleeding on continuous use, breast tenderness, headache, and mood change in some women.
🔬 Monitor
BP and BMI at the start and at each contraceptive review. Recheck UKMEC when her history changes. Consider potassium in the first cycle if she takes potassium-raising drugs (SPC). Repeat the diary after 2–3 cycles.
💬 Counselling

"This pill works by stopping ovulation, which is what triggers the symptoms. Taking it back-to-back without the usual break tends to work better for this, although that is outside the licence. There's a small increase in clot risk, higher than some other pills, so here are the warning signs: a painful swollen leg, chest pain or sudden breathlessness."

SCA: a good answer names drospirenone, continuous use, the UKMEC check and the VTE trade-off in one breath.

Transdermal oestradiol + progestogen protection
Oestradiol patch or gel + LNG-IUS 52 mg (or cyclical oral/vaginal progesterone)
Second lineLowest effective dose; specialist-supported, off-label
✓ Prefer when
First-line options have failed or are unsuitable, and she wants ovulation suppression. Usually started with gynaecology advice.
Perimenopausal women, where it may help both conditions (NICE NG23 for the menopause part).
✗ Avoid / caution
A uterus without progestogen protection: risk of endometrial hyperplasia.
Progestogen intolerance: use the lowest dose. Micronised progesterone or the LNG-IUS may re-trigger symptoms less often. The LNG-IUS alone is not a PMS treatment.
⚠ Side effects
Breast tenderness, unscheduled bleeding, skin irritation from patches, and PMS-like symptoms from the progestogen.
🔬 Monitor
Bleeding pattern (unscheduled bleeding needs assessment), progestogen side effects, and the diary response.
💬 Counselling

"The patch keeps your oestrogen level steady, which usually damps down the monthly cycle, although it may not reliably stop ovulation. The coil protects the womb lining. The patch is not a contraceptive on its own, so we'll use the coil or another method as well."

SCA: the contraception point ("oestradiol patches are not contraceptive") is the detail examiners look for.

GnRH analogue + add-back HRT
e.g. goserelin, leuprorelin (specialist-initiated; off-label for PMS)
Specialist onlyDose per specialist / SPC
✓ Used when
Severe or refractory PMDD after first- and second-line treatment. Also as a roughly 3-month diagnostic trial, and before considering surgery (RCOG GTG 48).
✗ Cautions
Bone loss: add-back HRT (continuous combined HRT or tibolone) if used for more than 6 months; annual DEXA on long-term treatment. Menopausal symptoms without add-back. Check contraception advice with the specialist and the SPC.
⚠ Side effects
Hot flushes, sweats, vaginal dryness, low mood, and reduced bone density.
🔬 Monitor
Specialist-led. The GP role is shared-care prescribing if agreed, checking that add-back is taken, and making sure DEXA is arranged.
💬 Counselling

"This puts your ovaries to sleep for a while, like a reversible menopause. If it works, it confirms the cycle is the cause. We add back a low dose of HRT to protect your bones."

SCA: you don't prescribe it, but you should know it exists and that it needs add-back therapy. That reassures a patient that there are options beyond first line.

Not recommended for PMS
Progesterone / progestogens alone · High-dose vitamin B6 · Endometrial ablation · Hysterectomy keeping the ovaries
Do not use
✗ Why
Progesterone/progestogens: no clinically meaningful benefit over placebo, and they can reproduce PMS symptoms (RCOG GTG 48).
High-dose B6: peripheral neuropathy. Keep supplements to 10 mg/day or less unless a doctor advises otherwise (NHS).
Surgery that keeps the ovaries: ovulation continues, and so do the symptoms (RCOG GTG 48).
💬 Counselling

"You might read about progesterone for PMS. The good-quality trials show it doesn't help, and it can make things worse, so I won't suggest it."

SCA: knowing what not to prescribe, and saying why, earns marks for clinical knowledge.

7F — Psychosocial impact of the diagnosis: family, work, driving & identity
🤝
PMDD: two weeks a month as "someone else", and the family, job and self-image that absorb the damage

The illness is cyclical, but the consequences add up. Relationships are strained by repeated luteal conflict, performance at work dips in a predictable pattern, and a woman's sense of herself as a good mother erodes. Naming these impacts, and planning for them, is part of treatment.

👨‍👩‍👧
Family, Partner and Children

Luteal irritability lands on the people closest to her. Partners may start to see her as the problem, and children notice the pattern. After each episode comes guilt, which feeds the hopelessness in the next cycle.

With her consent, involving her partner turns the pattern into something they face together, with a shared plan for the difficult days. Children can be given simple, age-appropriate explanations. If there is any concern about the children's welfare or safety at home, follow local safeguarding procedures.

"Would it help if your partner came to the next appointment? When the people at home understand this is a treatable condition, they can help you through the difficult days instead of it turning into an argument."
🏠
Safety at Home: Domestic Abuse

"Irritability" and "relationship conflict" can sometimes be the visible part of an abusive relationship. PMDD does not cause abuse, and abuse is never the victim's fault, even when she blames her own behaviour.

Ask safely, when she is alone: "Do you ever feel frightened of your partner?" If she says yes, follow local domestic abuse pathways and think about any children in the household.

"I ask everyone this: do you feel safe at home? Has anyone ever hurt you or made you feel afraid?"
💼
Work and Study

Concentration, energy and patience dip in a predictable window. Some women take repeated short absences that are recorded as unrelated minor illnesses.

A fit note is rarely needed. Reasonable adjustments help more: flexible deadlines, the option to work from home on the worst days, and moving demanding tasks to the follicular phase. Severe, long-term PMDD may meet the Equality Act definition of disability, so explain this to her rather than deciding it for her.

"Would it help to have a letter that explains this is a medical condition with a predictable pattern? Many employers can make small changes around those two weeks."
🚗
Driving and the DVLA

DVLA guidance does not name PMS or PMDD. Check the current DVLA guidance on depression and anxiety: it says that someone with severe symptoms, including significant memory or concentration problems, agitation, behavioural disturbance or suicidal thoughts, must not drive and must tell the DVLA. People with milder symptoms without those features do not need to tell the DVLA.

Discuss this with Leila and record the discussion. Tell her not to drive whenever she has suicidal thoughts, agitation or poor concentration, and that if her symptoms meet the DVLA description she must tell the DVLA. If you are unsure whether she meets it, check the DVLA guidance or ask the DVLA medical advisers rather than deciding for her. Also warn that some SSRIs cause drowsiness at first.

"On any day when you're having thoughts about not being here, or feel agitated or can't concentrate, please don't drive. Get a lift or use other transport. The DVLA has rules for when mood symptoms mean you need to tell them, so let's look at those together."
👤
Identity and Shame

Many women describe two selves: the capable woman of the follicular weeks and the "monster" of the luteal ones. Years of being told it's "just PMS" can leave deep shame and a fear of being "mad".

A diagnosis with a name, a mechanism and treatment is itself a psychological intervention. Peer support from patient organisations (e.g. the National Association for Premenstrual Syndrome, or IAPMD) reduces isolation.

"The person you are in your good weeks is you. What happens in the bad weeks is the condition acting on your brain. Your guilt shows how much you care. It doesn't show that you're a bad mother."
🤰
Fertility, Pregnancy and Future Plans

Treatment choices depend on family plans. A COC and ovulation suppression cannot be used while trying to conceive. SSRIs need a discussion before conception.

A history of PMDD is worth flagging for the perinatal period. Ask about mood at booking and after the birth, because women with hormone-sensitive mood symptoms may be more vulnerable then.

"Are you thinking about more children in the next year or two? That changes which treatment makes most sense, and it's something we'd plan around together."
7G — Follow-up schedule
1
Today: Safety, Diary, First-Line Measures

Direct risk assessment, documented as a formulation of her needs and safety. Do not assign a risk score (NICE NG225). Write a luteal-phase safety plan and give crisis numbers. Start the DRSP. Give lifestyle advice and the NHS Talking Therapies self-referral route. Arrange TFTs or FBC only if a mimic is suspected. If severity or the suicidal thoughts justify starting an SSRI or COC before the diary is complete, record the reason (severity or risk; the diary continues), screen for bipolar disorder before an SSRI, and complete the UKMEC 2025 check and BP/BMI before a COC.

Risk + safety planStart diary
2
1 Week (if SSRI started) or 2–4 Weeks (phone): Early Check

If she started an SSRI: review within 1 week because of the luteal suicidal thoughts (NICE NG222, increased risk). Ask about side effects, agitation and worsening thoughts. Otherwise, a short phone call before her next luteal phase to check the safety plan is in place and that she is keeping the diary.

Early SSRI reviewSafety plan check
3
After 2 Cycles (~8 Weeks): Diary Review and Diagnosis

Go through the diary together. A luteal pattern with a symptom-free week confirms PMS or PMDD, so agree or continue first-line treatment. Symptoms all month mean a primary mood disorder, so manage as that (NICE NG222). Repeat the risk review.

Confirm diagnosisRisk review
4
After 2–3 Treated Cycles: Judge the Response

Repeat the diary. Good response: continue, and review contraception and BP yearly if she is on a COC. Partial response: change regimen (luteal to continuous SSRI, a different SSRI, a continuous COC) or combine SSRI with COC. No response: move to second line or refer.

Step up or combine
5
Refractory or Uncertain: Refer; Then Ongoing Review

If simple measures (COC, SSRI, vitamin B6) have failed and severity justifies it, refer routinely to gynaecology or a specialist premenstrual disorder clinic, with the diaries and a treatment history. Refer to mental health if risk rises or the diagnoses overlap. Long term: review at least yearly, re-check UKMEC, ask about mood and plans, and reassess in the perimenopause.

Gynae / specialist PMDAnnual review
7H — Monitoring: mood and risk, response, and drug safety

Memory rule: monitoring in PMS / PMDD

At every contact: Ask about suicide directly, and ask how the worst days were, not today. Look at the diary: pattern and scores. Check the drug: SSRI side effects and agitation; COC with BP, BMI and UKMEC. Screen for bipolar again if mood lifts abnormally. Take the social temperature: home, children, work, alcohol.

WhatTest / checkWhenAction threshold
Suicidal thoughts, self-harmDirect questions; formulation of needs and safety (no risk scores, NICE NG225)Every contact; 1 week after starting an SSRI if at increased riskIntent, plan or recent self-harm → same-day crisis or liaison mental-health assessment; 999 if immediate danger. Thoughts becoming more frequent → review the plan and consider a mental-health referral.
Diagnosis and responseDRSP or equivalent prospective diaryBaseline 2 cycles; repeat after 2–3 treated cyclesNo symptom-free week → primary mood disorder. Little change on treatment → change regimen, combine, or step up.
SSRI tolerabilitySide effects, agitation, sexual function, bleeding1 week (if at risk); each reviewNew agitation or worse suicidal thoughts → same-day review. Intolerable side effects → change SSRI or regimen.
Bipolar switchElevated mood, reduced need for sleep, impulsivityEach review after starting an SSRIHypomanic features → stop or review the SSRI; urgent psychiatric advice (NICE CG185).
COC safetyBP, BMI, UKMEC 2025 re-check, VTE symptomsAt the start; then at least yearlyNew UKMEC 3/4 condition (e.g. migraine with aura, high BP) → stop or switch.
Drospirenone + potassium-raising drugsSerum potassiumConsider in the first cycle (SPC)Raised potassium → review the combination.
Vitamin B6 usersDose; tingling or numbnessEach reviewNeuropathic symptoms → stop the supplement.
Oestradiol + progestogenBleeding pattern, progestogen side effectsEach reviewUnscheduled bleeding → assess. Symptoms returning on the progestogen → review the route or dose with gynaecology.
GnRH analogue (specialist)Add-back adherence; DEXAAnnual DEXA on long-term treatmentFalling bone density → specialist review of whether to continue (RCOG GTG 48).
Function and relationshipsWork days lost, family conflict, alcohol (AUDIT-C)Each reviewWorsening → revisit CBT, involve her partner, and ask again about domestic abuse.
7I — Safety-netting: exact phrases, RAG marking and danger zones

⚠ Three scenario-specific phrases: use these verbatim

🔴 Emergency: the thoughts become a plan
"If the thoughts about not being here ever become stronger than passing thoughts — if you start planning, or feel you might act on them — that's an emergency, even if you know it will lift after your period. Ring 999 or go to A&E if you're in immediate danger. Otherwise call NHS 111 and choose the mental-health option, or call the Samaritans (number on their website) any time, day or night. And please tell us the same day."
Luteal suicidality can escalate within days, then lift with the period, and that pattern can hide how dangerous it is. The crisis route has to work at 2am on day 26 of her cycle, not only during surgery hours. NICE NG225 asks for a safety plan built with the person, not a risk score.
💊 After starting an SSRI
"In the first couple of weeks some people feel more restless or anxious, or have darker thoughts before things get better. If that happens, don't wait for your appointment. Call us the same day. And if you ever feel unusually high, wired, or you stop needing sleep, stop the tablets and ring us."
Early activation and suicidal thoughts are recognised risks in the first weeks, especially under 25 (MHRA). A switch to mania would suggest undiagnosed bipolar disorder (NICE CG185).
🟠 On the combined pill
"Very rarely this pill causes a blood clot. If you get a painful swollen calf, chest pain, sudden breathlessness, or a sudden severe headache or problems with your vision or speech, get urgent help. Call 999 if it's chest pain or stroke symptoms. And if your headaches change or you start getting warning signs before them, like zigzag lights, tell us, because that changes whether this pill is safe for you."
Drospirenone COCs carry a higher VTE risk than levonorgestrel COCs (MHRA 2014). New migraine with aura makes a combined pill UKMEC 4, so patients need to know to report it.
🔴🟠🟢 RAG: all 3 domains
Tasks
🟢
Luteal pattern and symptom-free week established; direct suicide questions and a safety plan; bipolar screened; 2-cycle diary; no hormone "tests"; SSRI (continuous or luteal) and/or drospirenone COC with UKMEC and VTE discussion; CBT; knows the GnRH and specialist route; early review
🟠
Recognises PMS but risk questions are vague; diary suggested without explaining why; COC offered without a UKMEC or VTE check; SSRI offered without the luteal option
🔴
No suicide questions; diagnoses on recall alone or orders "hormone levels"; SSRI without a bipolar screen; prescribes progesterone; "just PMS"
Relating to Others
🟢
Names her fear of being "mad" or bipolar and answers it; separates her character from her symptoms; asks about the dark thoughts gently and directly; shares the choice between SSRI and COC; offers to involve her partner
🟠
Kind but formulaic; shame acknowledged but not reframed; plan decided for her
🔴
Dismissive ("everyone gets PMS"); alarmed or judgemental about the suicidal thoughts; lectures about her behaviour towards her children
Global Skills
🟢
Covers risk, the diagnosis and a plan within 12 minutes; clear verbatim safety-net with crisis numbers; checks understanding; follow-up booked
🟠
Right content but runs out of time before the safety-net; jargon ("luteal", "DRSP") not explained
🔴
Disorganised; no safety-net; no follow-up
💬 Key phrases
💭 "Am I bipolar?"
"Bipolar disorder doesn't follow your periods, and you've never had spells of feeling high or not needing sleep. What you describe is premenstrual dysphoric disorder, a recognised condition we can treat."
😟 Asking about suicide
"You said your family might be better off without you. Some women with this condition have thoughts of ending their life on the worst days. Have you had thoughts like that? Have you ever made a plan?"
🎯 Why a diary
"A blood test can't show this, but a daily diary can. Two months of ticks on a chart will tell us for certain, and show later whether treatment is working."
🙏 Relieving shame
"You're not a bad mother. You're a mother with an untreated condition that affects your mood for two weeks a month. How much this upsets you shows how much you care."
🧠 Explaining the cause
"Your hormone levels are normal. Your brain is extra sensitive to the normal monthly changes. That's why a tablet that works on brain chemistry, or a pill that stops the monthly cycle, can both help."
📋 Safety-net close
"If the thoughts ever become more than passing, call 999 or NHS 111, or the Samaritans (number on their website), and tell us the same day. I'll see you in a week to check how the tablet is going."
🚫 8 Danger zones
✗
Not asking about suicide because "it goes away"→ Ask directly every time. The risk is real in the luteal phase. Safety plan, not a risk score (NICE NG225).
✗
Diagnosing on recall alone→ Prospective diary over 2 cycles (RCOG GTG 48). Recall over-reports.
✗
Missing depression that runs all month→ No symptom-free week means a primary mood disorder. Treat that (NICE NG222).
✗
SSRI without a bipolar screen→ Ask about highs and family history. If present, get psychiatric advice first (NICE CG185).
✗
Ordering "hormone levels" to diagnose→ Hormone levels are normal in PMS. Bloods only to exclude mimics.
✗
COC without a UKMEC or VTE check→ Check UKMEC 2025 (migraine with aura, VTE, smoking at 35+). Discuss the drospirenone VTE trade-off.
✗
Prescribing progesterone for PMS→ Not effective and can provoke symptoms (RCOG GTG 48).
✗
Oestradiol patches treated as contraception→ Not contraceptive. Use the LNG-IUS or a barrier method, and always protect the endometrium.
🎓 SCA Checkpoint — Step 7TasksRelating to OthersGlobal Skills
A plan that scores
"Here's the plan: a symptom diary to confirm it, and because the dark days are so severe we can think about starting an SSRI sooner — which you can take all the time or just in the two weeks before your period, and it works quickly for this. A combined pill is another option that also covers contraception. Let's make a clear written plan for the worst days, and here's who to call: 999 or A&E if you're in immediate danger, NHS 111 and the mental-health option, or Samaritans (number on their website). I'll see you again within a week."
Deductions
  • No safety plan despite luteal suicidal thoughts
  • Treating "depression" with no regard to the cyclical pattern; missing the luteal-SSRI option
  • Not offering ovulation suppression / not knowing escalation
Premenstrual Disorder (PMDD) — SCA Consultation Scorecard
RCOG GTG 48 · Luteal pattern + diary · Risk assessment · SSRI/COCP · The mood-disorder mimic
0/ 33 pts
🌐
Global Skills
Structure, language, responsiveness
0/7
✓
Tasks
Clinical reasoning, diagnosis, management
0/15
🤝
Relating to Others
Communication, rapport, shared decisions
0/11
RAG Self-Assessment
🔴 Red
No risk assessment; PMDD vs mood disorder not distinguished; no diary; "just PMS" dismissal; bipolar missed; no safety plan
🟠 Amber
Cyclical pattern recognised; partial risk assessment; diary or treatment partial; validation partial; ICE partial
🟢 Green
PMDD identified via luteal pattern + diary; full risk assessment + safety plan; bipolar screened; SSRI (continuous/luteal) ± COCP + CBT; validated & de-shamed; ICE all three
011172533
Fail
Borderline
Pass
Strong pass
📋
Complete the checklist to see your score and feedback
"I don't really know how to explain it… for a week or two before my period I turn into someone I don't recognise — furious, crying, hopeless. I've even thought my family would be better off without me. Then my period comes and I'm completely fine again. I think I might be bipolar, or just a terrible person."
Who you are

Leila Hassan, 34, two children. For years, in the 10–14 days before each period you become intensely irritable, tearful, anxious and hopeless — you snap at your partner and kids and have had fleeting thoughts that they'd be better off without you. Within a day or two of your period starting it lifts and you feel completely normal — "like myself" — and you function well the rest of the month. You're frightened by the intensity and the dark thoughts, deeply ashamed of how you treat your family, and you wonder if you're "going mad" or bipolar. You have no symptoms in the week after your period. You're not on hormonal contraception and are otherwise well.

Hidden concerns (reveal if explored)

The dark thoughts (main): they frighten you; they're fleeting and you've never had a plan, but you've never told anyone. If asked gently, you'll disclose.

Shame: you feel like a bad mother. Being told it's a condition, not your character, is a huge relief.

Fear of being "mad"/bipolar: reassurance that this is cyclical and treatable helps enormously.

Contraception: you're open to the pill if it might help.

Clinical details if asked
  • Symptoms 10–14 days premenstrually; resolve within 1–2 days of bleeding; genuinely well the week after
  • Mood predominant: irritability/rage, tearfulness, anxiety, hopelessness; some bloating/breast tenderness
  • Fleeting luteal thoughts "they'd be better off without me"; no plan, no intent, never acted; some protective factors (your children)
  • No periods of feeling high/sped up/not needing sleep (no mania); no year-round low mood
  • No past psychiatric diagnosis; not on contraception; no medical problems; not pregnant
  • Significant impact on your relationship and your guilt about the children
Reactions at key moments
  • On being told it's PMDD, not bipolar: visibly relieved — "so there's a name for it?"
  • On the risk questions: hesitant but discloses if asked kindly; relieved to be taken seriously.
  • On the diary: happy to keep one.
  • On the SSRI working quickly / luteal option: surprised and encouraged.
  • Challenge line: "Be honest — does this mean there's something seriously wrong with me? Am I bipolar?"
"Please be honest with me — is something seriously wrong? Am I bipolar, or am I just a bad mother who can't control herself?"

Resolution: Leila is helped if the GP: (1) recognises the cyclical luteal pattern with a symptom-free week as PMDD, distinguishing it from a year-round mood disorder/bipolar, and arranges a prospective 2-cycle diary to confirm; (2) conducts a sensitive, thorough risk assessment of the luteal suicidal thoughts and makes a safety plan; (3) validates her and relieves her guilt, attributing the behaviour to a treatable condition; (4) offers effective treatment — an SSRI (continuous or luteal-phase) and/or a combined pill, plus lifestyle/CBT — and knows the specialist/GnRH escalation route; (5) reviews early. She stays frightened and ashamed if dismissed as "just PMS", if the risk and diagnosis aren't taken seriously, or if no clear treatment plan is offered.

🏥
Clinic Quick Reference
Premenstrual Disorder (PMDD) — Clinical Decision Framework
RCOG GTG 48 · Luteal pattern + diary · SSRI/COCP · Risk
▼expand
🔍 1 — Diagnose

Pattern: luteal-phase symptoms resolving with menses + a symptom-free week. PMDD = severe mood-predominant form with impairment. Confirm with a prospective ≥2-cycle diary (DRSP). Differentiate from a mood disorder with premenstrual exacerbation (symptoms all month) and bipolar. Always assess suicide/self-harm risk (luteal phase).

💊 2 — Treat (stepped)

1. Explanation, lifestyle + CBT for everyone (need not come before medication; start promptly if severe). 2. SSRI — continuous OR luteal-phase (works within days); and/or combined pill (continuous/drospirenone-containing) to suppress ovulation. 3. Escalate (specialist): GnRH analogues + add-back HRT; rarely surgery. Safety plan throughout; review early; specialist/gynae for severe/refractory.

🎓
SCA Quick Reference
PMDD — Consultation Playbook
Timing defines it · screen risk · diary confirms · treat & validate
▼expand
🎯 The three pivots that pass this case
1 · Assess the risk
PMDD raises luteal-phase suicide risk — a thorough risk assessment and safety plan are mandatory, despite monthly remission.
2 · Timing & the mimic
Symptom-free week = PMDD; symptoms all month = mood disorder with premenstrual exacerbation. Confirm with a 2-cycle diary.
3 · Treat & validate
SSRI (continuous/luteal — works fast) ± combined pill + CBT; relieve shame; know the GnRH/specialist escalation.
⛔ Don't skip the suicide-risk assessment · Don't diagnose on retrospective recall — use a prospective 2-cycle diary · Don't miss a year-round mood disorder or bipolar · Don't dismiss it as "just PMS" · Remember the luteal-only SSRI option and ovulation-suppression / GnRH escalation
Reviewed: July 2026 · citations verified against the primary sources listed